TechFlow, Aug 11 — According to Prnewswire, NASDAQ-listed company 180 Life Sciences Corp. (NASDAQ: ATNF) announced that on August 8, it sold through a private placement senior secured convertible notes (the "Convertible Notes") with an aggregate principal amount of approximately $156 million due 2028 to an institutional investor.
The company plans to use the net proceeds from the Convertible Notes offering to purchase additional ETH. This transaction further expands the company's recently announced ETH treasury management strategy. The company intends to provide regular updates to investors on its ETH holdings in the near term to ensure maximum transparency.
Add to Favorites
Share to Social Media
